| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/06/1999 | US5919687 Polynucleotide coding for neutral sphingomyelinase; for screening compounds for diagnosis and treatment of diseases; antiarthritic/antitumor/anticarcinogenic/anticholesterol agents; psychological/nervous system disorders |
| 07/06/1999 | US5919685 Hybrid polynucleotide |
| 07/06/1999 | US5919671 Antitumor antibiotic BMS-199687 |
| 07/06/1999 | US5919665 A soluble endotoxin-free recombinant fusion proteins used as immunogens; antitoxins for treatment of humans and animals |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919661 Polynucleotides encoding cytokine inducible regulatory protein |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919658 Human cystatin F |
| 07/06/1999 | US5919657 Polynucleotide |
| 07/06/1999 | US5919656 Genes encoding telomerase protein 1 |
| 07/06/1999 | US5919653 A recombinantly altered nucleotide sequence that codes for a neurotransmitter protein; treatment of epilepsy, stroke, multiple sclerosis, spinal cord injury, and other nervous system disorders |
| 07/06/1999 | US5919639 Ii peptide therapeutics to enhance antigen presentation |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919635 Using a genetic engineered receptor |
| 07/06/1999 | US5919628 Amino acid transporters and uses |
| 07/06/1999 | US5919620 Heat shock protein HSP72 of Streptococcus pneumoniae |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919480 Liposomal influenza vaccine composition and method |
| 07/06/1999 | US5919461 Nonpathogenic infectious bursal disease virus and vaccine |
| 07/06/1999 | US5919459 Compositions and methods for treating cancer and hyperproliferative disorders |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | US5919452 Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
| 07/06/1999 | US5919450 Glutathione S-transferase homolog |
| 07/06/1999 | US5919444 Method for decreasing severity of acute and chronic pancreatitis |
| 07/06/1999 | US5919443 Stable lyophilized pharmaceutical preparations of G-CSF |
| 07/06/1999 | US5919127 Oviductal catalase binding to the membranes of spermatozoa and uses thereof |
| 07/06/1999 | CA2233593A1 Novel protein molecules and uses therefor |
| 07/06/1999 | CA2182521C Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 07/06/1999 | CA2130762C Treatment of disease and conditions associated with macrophage infiltration |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2004764C Ancrod proteins, their preparation and use |
| 07/06/1999 | CA1340636C Dermorphin analogs, their methods of preparation, pharmaceutical compositions and methods of therapeutic treatment using the same |
| 07/06/1999 | CA1340633C Method and therapeutic compositions for the treatment of myocardial infarction |
| 07/06/1999 | CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids |
| 07/06/1999 | CA1340625C Cloned cardionatrin cdna |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/1999 | WO1999032644A2 Prostate cancer gene |
| 07/01/1999 | WO1999032643A2 Mood disorder gene |
| 07/01/1999 | WO1999032640A1 Antagonists of g-protein-coupled receptor |
| 07/01/1999 | WO1999032639A1 Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032632A1 Novel embryo-derived interleukin related factor molecules and uses therefor |
| 07/01/1999 | WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/01/1999 | WO1999032622A2 Semaphorin zsmf-3 |
| 07/01/1999 | WO1999032621A2 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032619A1 Genetic inhibition by double-stranded rna |
| 07/01/1999 | WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032611A1 A lipase expressed in endothelial cells and methods for its use |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032609A1 Molecules associated with the human fused gene |
| 07/01/1999 | WO1999032608A1 MULTIPLE DRUG RESISTANCE GENE atrD OF $i(ASPERGILLUS NIDULANS) |
| 07/01/1999 | WO1999032606A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032517A1 Molecules associated with the human suppressor of fused gene |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032513A1 Protein binding polypeptides |
| 07/01/1999 | WO1999032510A1 Kappa receptor opioid peptides |
| 07/01/1999 | WO1999032509A2 Hemiasterlin analogs |
| 07/01/1999 | WO1999032502A1 Pdzk1 protein containing pdz interaction domains |
| 07/01/1999 | WO1999032498A1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 07/01/1999 | WO1999032175A1 Method and device for in-situ formulation of a medicinal solution for parenteral application |
| 07/01/1999 | WO1999032150A1 Ace inhibitor-mmp inhibitor combinations |
| 07/01/1999 | WO1999032149A1 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER) |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | WO1999032144A1 Method for preventing/remedying mastitis |
| 07/01/1999 | WO1999032143A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | WO1999032142A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999032140A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 07/01/1999 | WO1999032138A1 Method for reducing susceptibility to hiv infection |
| 07/01/1999 | WO1999032137A1 Lymphotactin as an adjuvant |
| 07/01/1999 | WO1999032136A1 Chimeric proteins for the treatment of diabetes |
| 07/01/1999 | WO1999032135A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | WO1999032134A1 Substantially pure histidine-linked protein polymer conjugates |
| 07/01/1999 | WO1999032133A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 07/01/1999 | WO1999032116A1 Insoluble compositions for controlling blood glucose |
| 07/01/1999 | WO1999032083A1 Microparticles and their therapeutic or diagnostic use |
| 07/01/1999 | WO1999032080A2 Device for targeted immobilization of the thrombogenic inhibitor hirudine on polymer surfaces |
| 07/01/1999 | WO1999032072A1 Compositions and methods for treatment of alopecia |
| 07/01/1999 | WO1999032049A1 Acellular matrix grafts: preparation and use |
| 07/01/1999 | WO1999031990A1 Carbohydrate oxidase and use thereof in baking |
| 07/01/1999 | WO1999031982A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999024051A3 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |